686 related articles for article (PubMed ID: 19644887)
1. STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Ruiz B; Hachulla E; Diot E; Granel B; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Amoura Z; Fajardy I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Aug; 60(8):2472-9. PubMed ID: 19644887
[TBL] [Abstract][Full Text] [Related]
2. Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity.
Dieude P; Dawidowicz K; Guedj M; Legrain Y; Wipff J; Hachulla E; Diot E; Sibilia J; Mouthon L; Cabane J; Amoura Z; Crakowski JL; Carpentier P; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
J Rheumatol; 2010 May; 37(5):987-92. PubMed ID: 20231204
[TBL] [Abstract][Full Text] [Related]
3. Association of a functional polymorphism in the IRF5 region with systemic sclerosis in a Japanese population.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Hikami K; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2009 Jun; 60(6):1845-50. PubMed ID: 19479858
[TBL] [Abstract][Full Text] [Related]
4. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in STAT4 and IRF5 increase the risk of systemic sclerosis: a meta-analysis.
Xu Y; Wang W; Tian Y; Liu J; Yang R
Int J Dermatol; 2016 Apr; 55(4):408-16. PubMed ID: 26712637
[TBL] [Abstract][Full Text] [Related]
6. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4.
Dieudé P; Wipff J; Guedj M; Ruiz B; Melchers I; Hachulla E; Riemekasten G; Diot E; Hunzelmann N; Sibilia J; Tiev K; Mouthon L; Cracowski JL; Carpentier PH; Distler J; Amoura Z; Tarner I; Avouac J; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Nov; 60(11):3447-54. PubMed ID: 19877059
[TBL] [Abstract][Full Text] [Related]
7. The status of pulmonary fibrosis in systemic sclerosis is associated with IRF5, STAT4, IRAK1, and CTGF polymorphisms.
Zhao W; Yue X; Liu K; Zheng J; Huang R; Zou J; Riemekasten G; Petersen F; Yu X
Rheumatol Int; 2017 Aug; 37(8):1303-1310. PubMed ID: 28434122
[TBL] [Abstract][Full Text] [Related]
8. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.
Yin H; Borghi MO; Delgado-Vega AM; Tincani A; Meroni PL; Alarcón-Riquelme ME
Arthritis Rheum; 2009 Aug; 60(8):2468-71. PubMed ID: 19644876
[TBL] [Abstract][Full Text] [Related]
9. Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis.
Dieudé P; Guedj M; Wipff J; Avouac J; Fajardy I; Diot E; Granel B; Sibilia J; Cabane J; Mouthon L; Cracowski JL; Carpentier PH; Hachulla E; Meyer O; Kahan A; Boileau C; Allanore Y
Arthritis Rheum; 2009 Jan; 60(1):225-33. PubMed ID: 19116937
[TBL] [Abstract][Full Text] [Related]
10. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases.
Martínez A; Varadé J; Márquez A; Cénit MC; Espino L; Perdigones N; Santiago JL; Fernández-Arquero M; de la Calle H; Arroyo R; Mendoza JL; Fernández-Gutiérrez B; de la Concha EG; Urcelay E
Arthritis Rheum; 2008 Sep; 58(9):2598-602. PubMed ID: 18759272
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking, STAT4 and TNFRSF1B polymorphisms, and systemic lupus erythematosus in a Japanese population.
Kiyohara C; Washio M; Horiuchi T; Tada Y; Asami T; Ide S; Atsumi T; Kobashi G; Takahashi H;
J Rheumatol; 2009 Oct; 36(10):2195-203. PubMed ID: 19684152
[TBL] [Abstract][Full Text] [Related]
12. Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).
Demirci FY; Manzi S; Ramsey-Goldman R; Minster RL; Kenney M; Shaw PS; Dunlop-Thomas CM; Kao AH; Rhew E; Bontempo F; Kammerer C; Kamboh MI
Ann Hum Genet; 2007 May; 71(Pt 3):308-11. PubMed ID: 17166181
[TBL] [Abstract][Full Text] [Related]
13. A single nucleotide polymorphism in the IRF5 promoter region is associated with susceptibility to rheumatoid arthritis in the Japanese population.
Shimane K; Kochi Y; Yamada R; Okada Y; Suzuki A; Miyatake A; Kubo M; Nakamura Y; Yamamoto K
Ann Rheum Dis; 2009 Mar; 68(3):377-83. PubMed ID: 18408250
[TBL] [Abstract][Full Text] [Related]
14. Association of the FAM167A-BLK region with systemic sclerosis.
Ito I; Kawaguchi Y; Kawasaki A; Hasegawa M; Ohashi J; Kawamoto M; Fujimoto M; Takehara K; Sato S; Hara M; Tsuchiya N
Arthritis Rheum; 2010 Mar; 62(3):890-5. PubMed ID: 20131239
[TBL] [Abstract][Full Text] [Related]
15. Association of a TRAF1 and a STAT4 gene polymorphism with increased risk for rheumatoid arthritis in a genetically homogeneous population.
Zervou MI; Sidiropoulos P; Petraki E; Vazgiourakis V; Krasoudaki E; Raptopoulou A; Kritikos H; Choustoulaki E; Boumpas DT; Goulielmos GN
Hum Immunol; 2008 Sep; 69(9):567-71. PubMed ID: 18625278
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Sigurdsson S; Göring HH; Kristjansdottir G; Milani L; Nordmark G; Sandling JK; Eloranta ML; Feng D; Sangster-Guity N; Gunnarsson I; Svenungsson E; Sturfelt G; Jönsen A; Truedsson L; Barnes BJ; Alm G; Rönnblom L; Syvänen AC
Hum Mol Genet; 2008 Mar; 17(6):872-81. PubMed ID: 18063667
[TBL] [Abstract][Full Text] [Related]
17. STAT4 gene polymorphism is associated with psoriasis in the genetically homogeneous population of Crete, Greece.
Zervou MI; Goulielmos GN; Castro-Giner F; Tosca AD; Krueger-Krasagakis S
Hum Immunol; 2009 Sep; 70(9):738-41. PubMed ID: 19500629
[TBL] [Abstract][Full Text] [Related]
18. Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population.
Kobayashi S; Ikari K; Kaneko H; Kochi Y; Yamamoto K; Shimane K; Nakamura Y; Toyama Y; Mochizuki T; Tsukahara S; Kawaguchi Y; Terai C; Hara M; Tomatsu T; Yamanaka H; Horiuchi T; Tao K; Yasutomo K; Hamada D; Yasui N; Inoue H; Itakura M; Okamoto H; Kamatani N; Momohara S
Arthritis Rheum; 2008 Jul; 58(7):1940-6. PubMed ID: 18576330
[TBL] [Abstract][Full Text] [Related]
19. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
[TBL] [Abstract][Full Text] [Related]
20. STAT4: a risk factor for type 1 diabetes?
Zervou MI; Mamoulakis D; Panierakis C; Boumpas DT; Goulielmos GN
Hum Immunol; 2008 Oct; 69(10):647-50. PubMed ID: 18703106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
